Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?

Journal of clinical psychopharmacology - 1 Oct 2005

Mosyagin Igor, Cascorbi Ingolf, Schaub Rainer, Krüger Timo, Dettling Michael

Abstract excerpt

Drug-induced agranulocytosis is a rare but life-threatening side effect which is possibly based on immunogenetic mechanisms. Some studies regarding agranulocytosis induced by the atypical antipsychotic clozapine dealing with HLA subtyping and enzyme polymorphisms have been performed to elucidate its genetic background. To further screen possibly genetically based pathways of developing agranulocytosis, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Clozapine
Share to DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibrinolytic Agents

Share to Genotype

Share to Leukocyte Count

Share to Receptors, IgG

Share to Ticlopidine

Source

Identifiers

PMID: 16160618
DOI: 10.1097/01.jcp.0000177551.13714.33

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?PMID 16160618Read ↗

Clozapine-induced agranulocytosis and its genetic determinants.Semantic proximity Read ↗

[Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].Semantic proximity Read ↗

Clozapine rechallenge after excluding the high-risk clozapine-induced agranulocytosis genotype of HLA-DQB1 6672G>C.Semantic proximity Read ↗

Pharmacogenomics of Clozapine-induced agranulocytosis: a systematic review and meta-analysis.Semantic proximity Read ↗

Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens.Semantic proximity Read ↗

Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.Semantic proximity Read ↗

Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry.Semantic proximity Read ↗

Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis.Semantic proximity Read ↗

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and AgranulocytosisSemantic proximity Read ↗

Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population.Semantic proximity Read ↗

HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients.Semantic proximity Read ↗

Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: no association with myeloperoxidase and cytochrome P4502D6.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.